NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols

Anna Bratasz(The Ohio State University), Periannan Kuppusamy(The Ohio State University)
Journal of Translational Medicine
February 26, 2008
Cited by 57


Related Papers